Information for "Daratumumab and hyaluronidase (Darzalex Faspro)"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Daratumumab and hyaluronidase (Darzalex Faspro) |
| Default sort key | Daratumumab and hyaluronidase (Darzalex Faspro) |
| Page length (in bytes) | 4,059 |
| Page ID | 2785 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Jwarner (talk | contribs) |
| Date of page creation | 19:18, 2 May 2020 |
| Latest editor | Warner-admin (talk | contribs) |
| Date of latest edit | 01:02, 29 June 2024 |
| Total number of edits | 14 |
| Total number of distinct authors | 4 |
| Recent number of edits (within past 90 days) | 2 |
| Recent number of distinct authors | 1 |